04 Aug The geko® device Secures NHS Supply Chain Listing on the Advanced Wound Care Framework
We are proud to announce the geko device has secured NHS Supply Chain (NHSSC) listing on the Advanced Wound Care framework—a significant milestone that enhances access to the geko device across the UK.
“The listing is more than a procurement achievement—it is recognition of the geko device’s clinical value in accelerating chronic wound healing and improving patient outcomes,” said Bernard Ross, Founder and CEO of Sky Medical Technology. “Our goal has always been to provide evidence-based, cost-effective solutions that support the NHS and its commitment to high-quality care.”
With real-world and peer-reviewed evidence supporting its benefits—accelerated healing, reduced oedema and pain, and lower treatment costs—the geko device is well-aligned with NHS priorities for improved efficiency, patient outcomes, and environmental sustainability. Its use can also significantly reduce the burden on wound care nurses, whose workforce has declined by nearly 50% over the past decade.
Fiona Young, Business Director for Wound at Firstkind, added:
“Inclusion in the NHSSC catalogue makes it easier for clinicians to integrate the geko device into care pathways, ensuring more patients can benefit from innovative treatment options.”
To support adoption, Firstkind has developed a clear clinical pathway in collaboration with wound care professionals. This pathway guides clinicians in identifying the optimal timing for introducing the geko device as an adjunctive therapy—maximising clinical effectiveness and delivering strong economic value.
In summary: The NHSSC listing marks a pivotal step in expanding access to an evidence-based, cost-efficient technology—offering faster healing, better patient care, and meaningful support for NHS clinicians.
Link to news article: https://www.gekodevices.com/news-events/the-geko-device-awarded-nhssc-listing-as-part-of-the-advanced-wound-care-tender/
No Comments